Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22

Clinical Trial ID NCT01884740

PubWeight™ 4.93‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01884740

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy. Oncoimmunology 2014 1.05
2 Reassessing the Role of Intra-Arterial Drug Delivery for Glioblastoma Multiforme Treatment. J Drug Deliv 2015 0.83
3 Recent advances and future of immunotherapy for glioblastoma. Expert Opin Biol Ther 2016 0.77
4 Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW. Br J Neurosurg 2015 0.77
5 Advances in paediatric cancer treatment. Transl Pediatr 2014 0.76
6 Pediatric Brain Tumors: Current Knowledge and Therapeutic Opportunities. J Pediatr Hematol Oncol 2016 0.75
Next 100